Insider trading

Period: 120 months Stock: BDX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

159 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

159 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

159 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

159 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
159 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
159 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

159 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Sep 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$13.96K 76 at 183.70
0.4%
Planned (10b5-1)
26 Aug 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$31.10K 165 at 188.49
0.8%
Planned (10b5-1)
13 Aug 2026
Polen Thomas E Jr Chairman, CEO and President
Sold on a plan
$768.12K 4,152 at 185.00
3.6%
Planned (10b5-1)
11 Aug 2026
Goette Roland EVP and President, EMEA
Sold at will
$440.89K 2,438 at 180.84
14.1%
Not planned
27 Jul 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.78K 75 at 157.13
0.4%
Planned (10b5-1)
26 Jun 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.46K 75 at 152.80
0.4%
Planned (10b5-1)
24 Jun 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$160.23K 1,100 at 145.66
7.7%
Planned (10b5-1)
10 Jun 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$166.63K 1,100 at 151.48
7.2%
Planned (10b5-1)
1 Jun 2026
Polen Thomas E Jr Chairman, CEO and President
Sold on a plan
$404.51K 2,764 at 146.35
2.4%
Planned (10b5-1)
26 May 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.05K 75 at 147.35
0.4%
Planned (10b5-1)
27 Apr 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.24K 74 at 151.94
0.3%
Planned (10b5-1)
26 Mar 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$11.76K 75 at 156.83
0.4%
Planned (10b5-1)
26 Feb 2026
Feld Michael EVP, Chief Revenue Officer
Sold on a plan
$13.64K 75 at 181.84
0.4%
Planned (10b5-1)
18 Feb 2026
SCOTT BERTRAM L Director
Sold at will
$174.03K 953 at 182.61
2.5%
Not planned
26 Jan 2026
Feld Michael EVP, CRO & Pres. Life Sciences
Sold on a plan
$15.20K 75 at 202.73
0.5%
Planned (10b5-1)
15 Jan 2026
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan 2×
$334.01K 1,610 at 207.46
11.7%
Planned (10b5-1)
26 Dec 2025
Feld Michael EVP, CRO & Pres. Life Sciences
Sold on a plan
$14.51K 74 at 196.08
0.4%
Planned (10b5-1)
17 Dec 2025
Garrison Michael David EVP & Pres Med.Essntl&BioPharm
Sold on a plan
$123.30K 629 at 196.03
4.6%
Planned (10b5-1)
1 Dec 2025
Feld Michael EVP, CRO & Pres. Life Sciences
Sold on a plan
$14.50K 75 at 193.36
0.5%
Planned (10b5-1)
7 Nov 2025
SCOTT BERTRAM L Director
Sold at will
$38.32K 217 at 176.58
0.6%
Not planned
27 Oct 2025
Feld Michael EVP & President, Life Sciences
Sold on a plan
$10.60K 57 at 186.01
0.7%
Planned (10b5-1)
26 Sep 2025
Feld Michael EVP & President, Life Sciences
Sold on a plan
$10.50K 58 at 181.03
0.7%
Planned (10b5-1)
10 Sep 2025
Fraser Claire Director
Sold at will
$171.94K 917 at 187.50
4.0%
Not planned
22 Aug 2025
Feld Michael EVP & President, Life Sciences
Sold on a plan
$11.29K 57 at 197.99
0.7%
Planned (10b5-1)
11 Aug 2025
HAYES GREGORY Director
Bought
$1.01M 5,250 at 191.57
660%
First buy on file
8 Aug 2025
Fraser Claire Director
Sold at will
$165.95K 863 at 192.30
3.6%
Not planned
18 Jul 2025
Garrison Michael David EVP & President, Medical
Sold on a plan 2×
$213.64K 1,185 at 180.29
19.5%
Planned (10b5-1)
2 Jun 2025
Shan David EVP and Chief ISC Officer
Sold on a plan
$199.61K 1,166 at 171.19
20.3%
Planned (10b5-1)
9 Apr 2025
Garrison Michael David EVP & President, Medical
Sold on a plan
$94.50K 479 at 197.28
8.9%
Planned (10b5-1)
18 Mar 2025
Byrd Richard EVP & President Interventional
Sold on a plan
$105.57K 459 at 230.00
6.2%
Planned (10b5-1)
12 Mar 2025
Byrd Richard EVP & President Interventional
Sold on a plan
$436.33K 1,940 at 224.91
20.7%
Planned (10b5-1)
12 Feb 2025
SCOTT BERTRAM L Director
Sold at will
$159.59K 700 at 227.99
1.9%
Not planned
10 Feb 2025
Bought
$350.43K 1,500 at 233.62
23.0%
First buy on file
21 Jan 2025
Neal Shana Carol EVP and Chief People Officer
Sold on a plan
$188.88K 787 at 240.00
4.9%
Planned (10b5-1)
21 Jan 2025
Shan David EVP and Chief ISC Officer
Sold on a plan
$120.00K 500 at 240.00
8.0%
Planned (10b5-1)
17 Jan 2025
Garrison Michael David EVP & President, Medical
Sold on a plan
$141.20K 597 at 236.51
9.7%
Planned (10b5-1)
7 Jan 2025
Neal Shana Carol EVP and Chief People Officer
Sold on a plan
$185.18K 788 at 235.00
4.6%
Planned (10b5-1)
19 Dec 2024
Garrison Michael David EVP & President, Medical
Sold on a plan
$633.81K 2,838 at 223.33
31.6%
Planned (10b5-1)
9 Dec 2024
Goette Roland EVP and President, EMEA
Sold on a plan
$139.74K 638 at 219.03
4.3%
Planned (10b5-1)
6 Dec 2024
Goette Roland EVP and President, EMEA
Sold on a plan
$990.79K 4,483 at 221.01
15.6%
Planned (10b5-1)
6 Dec 2024
Neal Shana Carol EVP and Chief People Officer
Sold on a plan
$220.49K 1,000 at 220.49
5.6%
Planned (10b5-1)
5 Dec 2024
Shan David EVP and Chief ISC Officer
Sold on a plan
$330.38K 1,500 at 220.25
19.3%
Planned (10b5-1)
10 Jun 2024
Spoerel Thomas J SVP,Controller&Chief Acct Off
Sold on a plan
$71.79K 300 at 239.31
13.2%
Planned (10b5-1)
15 May 2024
Goette Roland EVP and President EMEA
Sold on a plan 3×
$781.22K 3,300 at 236.73
22.6%
Planned (10b5-1)
13 May 2024
Goette Roland EVP and President EMEA
Sold on a plan 3×
$781.12K 3,300 at 236.70
18.4%
Planned (10b5-1)
30 Apr 2024
Garrison Michael David EVP & President Medical
Sold on a plan
$399.27K 1,715 at 232.81
24.2%
Planned (10b5-1)
14 Mar 2024
Spoerel Thomas J SVP,Controller&Chief Acct Off
Sold on a plan
$67.20K 282 at 238.29
11.0%
Planned (10b5-1)
11 Dec 2023
Garrison Michael David EVP & President Medical
Sold on a plan
$288.02K 1,239 at 232.46
14.6%
Planned (10b5-1)
28 Nov 2023
Byrd Richard EVP & President Interventional
Sold on a plan
$514.14K 2,156 at 238.47
34.4%
Planned (10b5-1)
5 Sep 2023
Byrd Richard EVP & President Interventional
Sold on a plan
$125.99K 459 at 274.48
11.8%
Planned (10b5-1)
Showing 1–50 of 159. Page 1 of 4 Older →